Pharmaceutical Collaborative Robots Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Application (Picking and Packaging, Inspection of Pharmaceutical Drugs, Laboratory Applications), By End-use (Pharmaceutical Companies, Research Laboratories, Others), By Region, and By Competition

Market Overview

Global Pharmaceutical Collaborative Robots Market was valued at USD 64.60 million in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 9.17% through 2028. In the pharmaceutical sector, the importance of adhering to regulations and maintaining high-quality standards highlights the essential role of precision in manufacturing procedures. Collaborative robots play a critical part in achieving compliance by minimizing mistakes and variations, while also enhancing product quality through consistent and controlled processes. Moreover, the scarcity of skilled labor and the desire to improve workforce efficiency drive the adoption of pharmaceutical collaborative robots, streamlining operations through the automation of repetitive tasks. This allows human employees to focus their expertise on more valuable tasks, ultimately increasing overall productivity and operational efficiency.

Key Market Drivers

Improved Product Quality

The global pharmaceutical industry is renowned for its commitment to producing high-quality, safe, and effective medicines. Regulatory agencies, such as the FDA and EMA, enforce stringent standards to ensure the quality of pharmaceutical products. In this context, the utilization of collaborative robots, or "cobots," has gained significant traction. These robots are not just automating processes; they are also contributing to a critical factor that drives growth in the pharmaceutical industry—improved product quality.

One of the primary reasons pharmaceutical manufacturers are turning to collaborative robots is their ability to significantly reduce errors. Cobots are programmed to execute tasks with precision, leaving little to no room for human errors. Whether it's dispensing, packaging, or inspecting pharmaceutical products, cobots consistently perform these tasks, minimizing defects and ensuring product integrity. Fewer errors lead to fewer product recalls and regulatory violations, which in turn enhances the reputation of pharmaceutical companies.

Collaborative robots excel in maintaining a high degree of consistency in manufacturing processes. They are not affected by factors like fatigue or distractions, which can influence human operators. This consistency results in pharmaceutical products that are not only uniform in quality but also meet regulatory standards on a consistent basis.

Pharmaceutical manufacturers are under constant scrutiny to adhere to rigorous regulatory standards. Collaborative robots, equipped with the necessary sensors and automation technology, ensure compliance with these standards. They can precisely follow Good Manufacturing Practices (GMP) and Good Automated Manufacturing Practices (GAMP) guidelines, reducing the likelihood of regulatory violations and costly consequences.

Pharmaceutical products are highly sensitive to contamination. Collaborative robots, operating in controlled environments, minimize the risk of contamination associated with human contact. They are sterilizable, reducing the chances of introducing foreign particles or microbes into the manufacturing process. This not only improves product quality but also upholds patient safety.

Collaborative robots can be equipped with advanced vision systems that can perform meticulous inspections at a level of detail that may be challenging for human operators. They can identify imperfections, irregularities, and inconsistencies that might go unnoticed by the human eye. By detecting these issues early in the production process, cobots contribute to the delivery of pharmaceutical products of the highest quality.

Improved product quality translates into cost savings for pharmaceutical manufacturers. Reduced waste due to fewer defects and errors means less material and product wastage. This is a significant financial benefit that boosts the bottom line for pharmaceutical companies, making the investment in collaborative robots a financially sound decision.

Skilled Labor Shortages

The pharmaceutical industry is experiencing a period of remarkable growth and innovation, driven by an increased demand for medicines and a growing aging population. However, this surge in demand has coincided with a significant challenge: a shortage of skilled labor. To address this issue, pharmaceutical manufacturers are increasingly turning to collaborative robots, or "cobots," to fill the workforce gap.

The pharmaceutical industry is expanding rapidly, particularly with the emergence of new drug therapies and the need for vaccine production. This growth has outpaced the ability to train and hire skilled professionals. Many skilled pharmaceutical workers are nearing retirement, leading to a generational shift in the workforce. The loss of experienced professionals creates a vacuum that is challenging to fill. The pharmaceutical industry requires specialized knowledge in areas such as pharmaceutical engineering, quality control, and regulatory compliance. Acquiring this expertise takes time, which is often in short supply. The pharmaceutical sector operates under strict regulatory regimes, necessitating a workforce that is well-versed in compliance with Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP).

Collaborative robots can handle repetitive, mundane tasks, allowing the available skilled workforce to focus on higher-value, specialized work. This enables a more efficient use of existing skilled labor resources. Cobots are programmed to execute tasks with precision and consistency, reducing the risk of errors and variations that can occur when human operators are overburdened or inexperienced. Collaborative robots can operate continuously, which is particularly useful in the pharmaceutical industry, where certain processes need to run around the clock. This mitigates the challenges posed by limited work shifts and worker fatigue. By taking over repetitive and physically demanding tasks, collaborative robots relieve human workers from these burdens. This, in turn, improves overall workforce efficiency and job satisfaction. Cobots are designed to be user-friendly, with programming that can be easily learned by existing employees. This means that pharmaceutical companies can quickly integrate these robots into their operations. While the initial investment in cobots is significant, the long-term cost savings from reduced labor needs, improved product quality, and increased operational efficiency make them a cost-effective solution.

Workforce Efficiency

The pharmaceutical industry is a dynamic and highly regulated sector that demands precision, quality, and efficiency. However, maintaining workforce efficiency while adhering to strict regulatory requirements can be a daunting task. In recent years, the global pharmaceutical collaborative robots market has seen substantial growth, largely driven by the need to enhance workforce efficiency.

Stringent regulatory requirements necessitate meticulous documentation, quality control, and adherence to Good Manufacturing Practices (GMP). This places a significant administrative burden on the workforce. The pharmaceutical industry requires a skilled workforce with expertise in areas such as laboratory analysis, quality assurance, and regulatory affairs. However, the shortage of such skilled labor poses a significant challenge. The global demand for pharmaceutical products, including vaccines and innovative therapies, has surged. Meeting this demand while maintaining workforce efficiency is a complex endeavor. Pharmaceuticals must be produced with a high degree of safety and quality. Ensuring these standards is labor-intensive, and any compromise in these areas can have dire consequences.

Cobots excel at performing routine, repetitive tasks, such as labeling, packaging, and material handling. This automation relieves human workers from monotonous duties, enabling them to focus on higher-value, intellectually demanding tasks. Collaborative robots are programmed to execute tasks with precision and consistency. They do not suffer from fatigue or distractions and can work around the clock, ensuring a consistently high level of performance. The risk of errors and inconsistencies in pharmaceutical manufacturing is significantly reduced with cobots. These robots can perform tasks with minimal deviations, leading to fewer product defects and regulatory violations. Collaborative robots can be equipped with advanced vision systems that can inspect pharmaceutical products with great detail and accuracy. This ensures that products meet the highest quality standards. Cobots enhance workforce efficiency by enabling human workers to allocate their skills to more critical, non-repetitive tasks. This not only increases job satisfaction but also ensures that the right tasks are performed by the right personnel. The integration of cobots leads to cost savings by reducing labor needs and improving operational efficiency. The initial investment in these robots is offset by long-term gains in productivity and product quality.

Operational Effectiveness

The pharmaceutical sector operates under strict regulatory guidelines and quality standards, necessitating meticulous documentation and adherence to Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP). The production of pharmaceuticals involves intricate processes, including synthesis, formulation, packaging, and quality control, each with unique demands for precision and consistency. The industry grapples with a shortage of skilled labor, which is essential for tasks requiring expertise in laboratory analysis, quality assurance, and regulatory compliance. Certain pharmaceutical processes must operate continuously, necessitating a workforce that can handle 24/7 production.

Cobots are programmed to perform tasks with a high degree of precision and accuracy. They minimize errors, reducing defects in pharmaceutical products and minimizing the risk of costly regulatory violations. Cobots work tirelessly without experiencing fatigue or distractions, ensuring a consistent level of performance. This consistency is essential in pharmaceutical manufacturing to meet quality and regulatory standards. Cobots can be programmed to strictly adhere to regulatory requirements, such as GMP and GLP. Their documentation and data collection capabilities help streamline compliance efforts. The pharmaceutical industry requires a sterile environment. Cobots can operate in cleanrooms and controlled environments, reducing the risk of contamination associated with human workers. Collaborative robots can be equipped with advanced vision systems for meticulous inspection. They can detect imperfections and deviations in products, contributing to the delivery of pharmaceuticals of the highest quality. Cobots can operate around the clock, ensuring continuous production. This is especially important in pharmaceutical processes that cannot afford downtime.

Download Free Sample Report

Key Market Challenges

Cost of Implementation

While collaborative robots offer long-term cost savings, the initial investment can be substantial. Purchasing, integrating, and programming cobots can represent a significant financial commitment for pharmaceutical manufacturers. Smaller companies or those with limited budgets may find it challenging to make this initial investment in automation technology.

Complex Integration

Integrating collaborative robots into existing pharmaceutical manufacturing processes can be a complex endeavor. Each pharmaceutical facility has its unique workflow, machinery, and safety protocols. Ensuring that cobots seamlessly fit into these processes while adhering to safety standards requires careful planning and expertise.

Data Security

As pharmaceutical manufacturing processes become increasingly automated, the collection and analysis of sensitive data are on the rise. Protecting this data from cyber threats and ensuring data security is a critical concern. Pharmaceutical companies must invest in robust cybersecurity measures to safeguard their automated systems from potential breaches.

Key Market Trends

Enhanced Safety Features

Safety has always been a top priority in the pharmaceutical industry. Upcoming trends in collaborative robots include the integration of advanced safety features. These robots will have improved sensors and vision systems to avoid collisions with humans and other equipment. Compliance with rigorous safety standards, such as ISO 13849 and ISO 10218, will continue to be a focus.

Improved Human-Robot Collaboration

Pharmaceutical manufacturers are increasingly looking for ways to enhance the synergy between human workers and robots. This involves developing more intuitive interfaces and ergonomic designs, making it easier for employees to collaborate with cobots. Improved collaboration will lead to a smoother workflow, higher job satisfaction, and overall operational efficiency.

Miniaturization and Portability

As pharmaceutical manufacturing processes become more flexible and adaptable to market demands, there is a growing need for compact, portable collaborative robots. These smaller cobots can be easily reconfigured and transported to different locations within a facility, reducing the cost and time associated with changing production lines or processes.

Segmental Insights

Application Insights

Based on the category of Application, the picking and packaging sector asserted its supremacy in the market by securing the largest market share in 2022. This achievement can be attributed to the pivotal role this segment plays in the supply chain and manufacturing processes. Picking and packaging operations are instrumental in efficiently organizing, preparing, and dispatching products. Given the rising demand for streamlined logistics, the rapid growth of e-commerce, and the necessity for precision in delivering products to consumers, companies are giving high priority to automation solutions in these areas.

Consequently, investments in collaborative robots for picking and packaging have witnessed a remarkable surge, strengthening the segment's dominance in the 2022 market. Moreover, this segment is anticipated to experience the swiftest growth with a CAGR during the forecast period. This growth can be attributed to the capability of robots to enhance precision and efficiency while addressing complex material handling challenges. Furthermore, the pick-and-place approach offers these advantages while conserving floor space by operating within a limited work area, effectively optimizing workspace utilization. This trend reflects the industry's commitment to maximizing operational efficiency while ensuring efficient use of available space.

End-use Insights

Based on End-use, the pharmaceutical companies sector emerged as the dominant force in the market by securing the largest market share in 2022. This trend can be attributed to the increasing adoption of robotics in drug discovery and development. Additionally, the growth of this segment was fueled by pharmaceutical firms' active involvement in personalized medicine initiatives.

During the projected period, research laboratories are expected to undergo significant expansion, primarily due to the capacity of automation to handle repetitive tasks, such as the transfer of test tubes and fluids, in drug discovery endeavors. This automation enhances precision and consistency in these critical processes.

Moreover, this segment is anticipated to experience the most rapid growth with a CAGR during the forecast period. The industry's steadfast commitment to research and development ensures a continuous stream of improved products, further solidifying its position in the market. Meeting stringent regulatory standards for safety and efficacy also adds to the credibility of pharmaceutical offerings.

The global presence, robust distribution networks, and strategic partnerships of pharmaceutical companies amplify their influence. Collaborations with healthcare providers, academic institutions, and government agencies contribute to the expansion of their customer base.

Download Free Sample Report

Regional Insights

In 2022, the Asia Pacific region held the largest market share and is expected to experience substantial growth in the forecasted period. This growth is attributed to the presence of numerous local pharmaceutical companies, particularly in countries like Japan. The regional market is seeing significant expansion, primarily driven by the increasing adoption of automation in various industries within the region, aimed at optimizing their return on investment. Notably, China is witnessing a surge in the production, sale, and trade of collaborative robots (cobots), positioning itself as a key player in the Asia Pacific cobots market.

Conversely, North America is projected to achieve the fastest CAGR over the forecast period. The market's expansion in this region can be attributed to the substantial number of robot installations. According to data from the International Federation of Robotics, the American region recorded a remarkable 20% growth rate in robot deployment, marking a new record high for the sixth consecutive year. As a result, North America boasts a significant presence of pharmaceutical robots, a trend expected to continue due to the increasing number of pharmaceutical enterprises in the region. The IFR also highlighted North America's commitment to strengthening its pharmaceutical manufacturing capabilities for global competitiveness by embracing automation within its production facilities.

Recent Developments

• In June 2022, Becton, Dickinson, and Company, in collaboration with Frazier Healthcare Partners, concluded a formal agreement for BD's acquisition of Parata Systems, a forward-thinking provider of pharmacy automation solutions, at a total cost of USD 1.525 billion.
• In July 2020, SNC-Lavalin from Canada and Kinova joined forces in a two-year collaboration to introduce robotic solutions into the nuclear industry. SNC-Lavalin seamlessly integrated Kinova's technology into a patented and certified solution, streamlining the secure deployment of collaborative robots in various environments, including gloveboxes.
• In January 2020, ABB made an investment in MTEK, a robotics solution and software startup based in Sweden, as part of its venture capital initiative. This partnership aimed to enhance the capabilities of collaborative robots, particularly ABB's YuMi, through collaborative efforts to develop and implement advanced software, solutions, and services that enable intelligent and real-time collaborative production. 

Key Market Players

• ABB Limited
• Universal Robots A/S
• Mitsubishi Electric Corp
• KUKA AG
• Kawasaki Heavy Industries Ltd
• YASKAWA Electric Corporation
• Denso Wave Inc
• Fanuc America Corp

Report Scope:

In this report, the Global Pharmaceutical Collaborative Robots Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Pharmaceutical Collaborative Robots Market, By Application:

o   Picking and Packaging

o   Inspection of Pharmaceutical Drugs

o   Laboratory Applications

• Pharmaceutical Collaborative Robots Market, By End-use:

o   Pharmaceutical Companies

o   Research Laboratories

o   Others

• Pharmaceutical Collaborative Robots Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  Germany

§  United Kingdom

§  France

§  Italy

§  Spain

o   Asia-Pacific

§  China

§  Japan

§  India

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

§  Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Collaborative Robots Market.

Available Customizations:

Global Pharmaceutical Collaborative Robots market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Pharmaceutical Collaborative Robots Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]